Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 13, 2000 - Issue 4
206
Views
3
CrossRef citations to date
0
Altmetric
Articles

Erectile Dysfunction: Diagnosis and Management with Newer Oral Agents

Pages 356-360 | Published online: 11 Dec 2017

  • Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000;163: 460–463.
  • Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151: 54–61.
  • Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191–236.
  • Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326: 90–94.
  • Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little, Brown, 1970.
  • Morales A, Heaton JP, Carson CC III. Andropause: a misnomer for a true clinical entity. J Urol 2000;163: 705–712.
  • Grimm RH Jr, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997;157: 638–648.
  • Kerfoot WW, Park HY, Schwartz LB, Hagen PO, Carson CC III. Characterization of calcium channel blocker induced smooth muscle relaxation using a model of isolated corpus cavernosum. J Urol 1993;150: 249–252.
  • The process of care model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel. Int J Impot Res 1999;11: 59–70; discussion 70–74.
  • Montague DK, Barada JH, Belker AM, Levine LA, Nadig PW, Roehrborn CG, Sharlip ID, Bennett AH. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol 1996;156: 2007–2011.
  • Chamness SL, Ricker DD, Crone JK, Dembeck CL, Maguire MP, Burnett AL, Chang TS. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 1995;63: 1101–1107.
  • Baba K, Yajima M, Carrier S, Morgan DM, Nunes L, Lue TF, Iwamoto T. Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU Int 2000;85: 953–958.
  • Alcorn JF, Toepfer JR, Leipheimer RE. The effects of castration on relaxation of rat corpus cavernosum smooth muscle in vitro. J Urol 1999;161: 686–689.
  • Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, Schwacha MG. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol 1989;141: 1360–1363.
  • Vogt HJ, Brandl P, Kockott G, Schmitz JR, Wiegand MH, Schadrack J, Gierend M. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot Res 1997;9: 155–161.
  • Christ GJ, Maayani S, Valcic M, Melman A. Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol 1990;101: 375–381.
  • Carson CC. Advances in the pharmacologic treatment of erectile dysfunction. Contemporary Urology 1999;11: 102–107.
  • Meinhardt W, Schmitz PI, Kropman RF, de la Fuente RB, Lycklama a Nijeholt AA, Zwartendijk J. Trazodone, a double blind trial for treatment of erectile dysfunction. Int J Impot Res 1997;9: 163–165.
  • Carson CC III, Mino RD. Priapism associated with trazodone therapy. J Urol 1988;139: 369–370.
  • Montorsi F, Strambi LF, Guazzoni G, Galli L, Barbieri L, Rigatti P, Pizzini G, Miani A. Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. Urology 1994;44: 732–736.
  • Melman A. L-Arginine and penile erection. J Urol 1997;158 (3 Pt 1): 686.
  • Zorgniotti AW, Lizza EF. Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int J Impot Res 1994;6: 33–35.
  • Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338: 1397–1404.
  • Padma-Nathan H. Sildenafil citrate (Viagra): an update. Mol Urol 1999; 3: 127–134.
  • Montorsi F, McDermott TE, Morgan R, Olsson A, Schultz A, Kirkeby HJ, Osterloh IH. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 1999;53: 1011–1018.
  • Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract 1998;52: 375–379.
  • Hartmann U, Meuleman EJ, Cuzin B, Emrich HM, Declercq GA, Bailey MJ, Maytom MC, Smith MD, Osterloh IH. Sildenafil citrate (Viagra): analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction. Multicentre Study Group. Int J Clin Pract Suppl 1999;102: 27–29.
  • Heaton JP, Morales A, Adams MA, Johnston B, el-Rashidy R. Recovery of erectile function by the oral administration of apomorphine. Urology 1995;45: 200–206.
  • Padma-Nathan H, Fromm S, Ruff D, McMurray J, Rosen R. Efficacy and safety of apomorphine SL vs placebo for male erectile dysfunction. J Urol 1998;159: 241–243.
  • Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998;52: 739–743.
  • Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993;270: 713–724.
  • Wagner G, Lacy S, Lewis R. Buccal phentolamine: a pilot trial for male erectile dysfunction at three separate clinics. Int J Impot Res 1994;6: D78.
  • Gwinup G. Oral phentolamine in nonspecific erectile insufficiency. Ann Intern Med 1988;109: 162–163.
  • Becker AJ, Stief CG, Machtens S, Schultheiss D, Hartmann U, Truss MC, Jonas U. Oral phentolamine as treatment for erectile dysfunction. J Urol 1998;159: 1214–1216.
  • Zorgniotti AW. Experience with buccal phentolamine mesylate for impotence. Int J Impot Res 1994;6: 37–41.
  • Heaton JP, Adams MA, Morales A. A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative. Int J Impot Res 1997; 9: 115–121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.